Document is current
Any future updates will be listed below
-
Authors
Braun, Till https://orcid.org/0000-0002-0854-7815
Kuschel, Florian
Reiche, Kristin https://orcid.org/0000-0002-4452-4872
Merz, Maximilian https://orcid.org/0000-0002-2805-5973
Herling, Marco
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70113307)
Wilhelm Sander-Stiftung (2023.084.1)
José Carreras Leukämie-Stiftung (08 R/2023, 08 R/2023, 01 R_2023)
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (SaxoCell)
Deutscher Akademischer Austauschdienst (57616814)
- License Information
-
More Information
Article History
Received: 19 February 2025
Revised: 20 February 2025
Accepted: 17 March 2025
First Online: 7 April 2025
Competing interests
: MH gave advisory boards and received honoraria from Abbvie, Beigene, Jazz, Janssen, Stemline Menarini, and Takeda, and received research support from EDO-Mundipharma, Janpix, Novartis, and Roche. MM: Advisory Boards/Honoraria/Research support: Amgen, BMS, Celgene, Gilead, Janssen, Stemline, Springworks, and Takeda.
